CETRAXAL

LOE Approaching

ciprofloxacin hydrochloride

Salvat
NDAOTICSOLUTION/DROPS
Approved
May 2009
Lifecycle
LOE Approaching
Competitive Pressure
30/100

Mechanism of Action

(see 12.4 Clinical Pharmacology, Microbiology).

Indications (2)

acute otitis externa due to susceptible isolates of Pseudomonas aeruginosaStaphylococcus aureus
Company
Salvat
Salvat
FL - Miami
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers